Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Willan

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Clinical Trials (London, England)|November 26, 2008
Optimal sample size determinations from an industry perspective based on the expected value of informationAndrew R Willan
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Statistical analysis of cost-effectiveness data from randomized clinical trialsAndrew R Willan
Clinical Trials (London, England)|August 24, 2007
Clinical decision making and the expected value of informationAndrew R Willan
Trials|July 6, 2016
Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation studyAndrew R Willan
European Journal of Gastroenterology & Hepatology|May 29, 2004
Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trialAndrew R Willan
Pharmacoeconomics|October 13, 2011
Sample size determination for cost-effectiveness trialsAndrew R Willan
Pharmacoeconomics|May 18, 2012
Value of information and pricing new healthcare interventionsAndrew R Willan, Simon Eckermann
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2008
The option value of delay in health technology assessmentSimon Eckermann, Andrew R Willan
Clinical Trials (London, England)|April 17, 2020
Bayesian methods for pilot studiesAndrew R Willan, Lehana Thabane
Health Economics|April 29, 2009
Optimal clinical trial design using value of information methods with imperfect implementationAndrew R Willan, Simon Eckermann
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Clinical Trials (London, England)|November 26, 2008
Optimal sample size determinations from an industry perspective based on the expected value of informationAndrew R Willan
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Statistical analysis of cost-effectiveness data from randomized clinical trialsAndrew R Willan
Clinical Trials (London, England)|August 24, 2007
Clinical decision making and the expected value of informationAndrew R Willan
Trials|July 6, 2016
Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation studyAndrew R Willan
European Journal of Gastroenterology & Hepatology|May 29, 2004
Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trialAndrew R Willan
Pharmacoeconomics|October 13, 2011
Sample size determination for cost-effectiveness trialsAndrew R Willan
Pharmacoeconomics|May 18, 2012
Value of information and pricing new healthcare interventionsAndrew R Willan, Simon Eckermann
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2008
The option value of delay in health technology assessmentSimon Eckermann, Andrew R Willan
Clinical Trials (London, England)|April 17, 2020
Bayesian methods for pilot studiesAndrew R Willan, Lehana Thabane
Health Economics|April 29, 2009
Optimal clinical trial design using value of information methods with imperfect implementationAndrew R Willan, Simon Eckermann
Pageof 11